Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023)
Revolution Medicines (RVMD) EBITDA Margin Growth (1y) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1,997.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2.39 Mn |
| Jun 30, 2023 | -216,401.00 |
| Mar 31, 2023 | -30,683.00 |
| Dec 31, 2022 | 15,681.00 |
| Sep 30, 2022 | 254,813.00 |
| Jun 30, 2022 | -16,908.00 |
| Mar 31, 2022 | -39,557.00 |
| Dec 31, 2021 | -16,989.00 |
| Sep 30, 2021 | -461,101.00 |
| Jun 30, 2021 | -23,287.00 |
| Mar 31, 2021 | -18,654.00 |
| Dec 31, 2020 | -22,759.00 |
| Sep 30, 2020 | -10,919.00 |
| Jun 30, 2020 | -19,315.00 |
| Mar 31, 2020 | -10,333.00 |